Update in COVID guidelines

The ASP committee updated the COVID guidelines. You will find the following change:

-Removal of the pre-exposure prophylaxis guidelines since monoclonal antibodies are no longer easly available.

-Clarification on the Remdesivir dosing in CKD

-CT value should not guide treatment decision in patient with COVID since it was associated with morbidity in the MUHC.

Thank you!

Francois Bourdeau

Recent Posts

INESSS approved the TDM of Linezolid in May 2024 It is now available in the MUHC (via HSJ labs) The ASP committee is happy to publish a...

The ASP chairs are happy to publish the MUHC ASP annual report 2022-2023, now available in the Resources section of the MUHC ASP website....

The ASP committee is happy to give you an early Christmas gift! We published the guidelines on management and treatment of Staphylococcus...